Rates and Risk of Atrial Arrhythmias in Patients Treated With Ibrutinib Compared With Cytotoxic Chemotherapy-Reference-Cited by-同舟云学术

Rates and Risk of Atrial Arrhythmias in Patients Treated With Ibrutinib Compared With Cytotoxic Chemotherapy

Published:2019-08 Issue:4 Volume:124 Page:539-544
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Fradley Michael G.^ORCID,Gliksman Matthew,Emole Josephine,Viganego Federico,Rhea Isaac,Welter-Frost Allan,Armanious Merna,Lee Dae Hyun^ORCID,Walko Christine,Shah Bijal,Chavez Julio C.,McLeod Howard,Pinilla-Ibarz Javier,Schabath Matthew B.^ORCID

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference26 articles.

1. Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia;Byrd;N Engl J Med,2014

2. Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia;Burger;N Engl J Med,2015

3. Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study;Dreyling;Lancet,2016

4. Ibrutinib in previously treated Waldenstrom's macroglobulinemia;Treon;N Engl J Med,2015

5. Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials;Brown;Haematologica,2017

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pericardial events associated with ibrutinib‐based therapies for chronic lymphocytic leukaemia in two landmark trials;British Journal of Haematology;2024-09

2. Risk factors for arrhythmias occurred in cancer patients after chemotherapy: An evidence-based systematic review and meta-analysis;Heliyon;2024-07

3. A Comprehensive Review of Cancer Drug–Induced Cardiotoxicity in Blood Cancer Patients: Current Perspectives and Therapeutic Strategies;Current Treatment Options in Oncology;2024-02-19

4. Drug-induced atrial fibrillation. A narrative review of a forgotten adverse effect;Pharmacological Research;2024-02

5. Atypical atrial flutter: Exploring the relationship between ibrutinib chemotherapy and atrial myopathy;HeartRhythm Case Reports;2024-01